Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Journal article

Howard R. et al, (2012), N Engl J Med, 366, 893 - 903

Determining the minimum clinically important differences for outcomes in the DOMINO trial.

Journal article

Howard R. et al, (2011), Int J Geriatr Psychiatry, 26, 812 - 817

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.

Journal article

Oulhaj A. et al, (2010), Int J Geriatr Psychiatry, 25, 82 - 90

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).

Journal article

Ballard C. et al, (2009), Am J Geriatr Psychiatry, 17, 726 - 733

Contemporaneous assessment of testamentary capacity.

Journal article

Shulman KI. et al, (2009), Int Psychogeriatr, 21, 433 - 439

Donepezil for the treatment of agitation in Alzheimer's disease.

Journal article

Howard RJ. et al, (2007), N Engl J Med, 357, 1382 - 1392

How to assess capacity to make a will.

Journal article

Jacoby R. and Steer P., (2007), BMJ, 335, 155 - 157

Maina in old age

Journal article

Jacoby R., (2006), International Journal of Geriatric Psychiatry, 21